Pentamidine Isethionate (Seton Pharmaceuticals)


Welcome to the PulseAid listing for the Pentamidine Isethionate drug offered from Seton Pharmaceuticals. This Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Seton Pharmaceuticals
NON-PROPRIETARY NAME: Pentamidine Isethionate
SUBSTANCE NAME: PENTAMIDINE ISETHIONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiprotozoal [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-09-01
END MARKETING DATE: 0000-00-00


Pentamidine Isethionate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPentamidine Isethionate from Seton Pharmaceuticals
LABELER NAME: Seton Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/300mg)
START MARKETING DATE: 2013-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 13925-515_6e8bfef5-266c-480e-a2c2-0ec29db54cce
PRODUCT NDC: 13925-515
APPLICATION NUMBER: ANDA206666

Other PENTAMIDINE ISETHIONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APP Pharmaceuticals, LLCPentam 300
Fresenius Kabi USA, LLCNebuPent
Seton PharmaceuticalsPentamidine Isethionate